Armelle Prévost-Blondel

7PUBLICATIONS
25CO-AUTHORS
Tumour immunologyHaematological tumoursMedical mycologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 15, 2026
Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression.

Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias

|Feb 24, 2024
Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties.

Fériel Bekkat, Malvina Seradj, Renée Lengagne

|Aug 01, 2023
Deciphering the immune reaction leading to spontaneous melanoma regression: initial role of MHCII+ CD163- macrophages.

Fany Blanc, Nicolas Bertho, Guillaume Piton

|May 24, 2021
What role for AHR activation in IL4I1-mediated immunosuppression ?

Flavia Castellano, Armelle Prevost-Blondel, José L Cohen

|Sep 05, 2019
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade.

Nicolas Jacquelot, Takahiro Yamazaki, Maria P Roberti

|Sep 20, 2018
Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma.

Laetitia Douguet, Lloyd Bod, Laura Labarthe

Pageof 2

Frequent Collaborators

3 joint publications

Flavia Castellano

1 joint publications

Yolande Richard

1 joint publications

Maria P Roberti

1 joint publications

Connie P M Duong